Can Vaccine Allocation Plans Legally Respond to Racial Disparities?
Can COVID-19 vaccine allocation legally recognize the outsized burden of cases and deaths that racial/ethnic minority communities have borne?

Policy changes could help address the suffering this workforce has experienced and facilitate their continued care for people with serious illness.

Medical associations, health systems, and policymakers must work together to identify and remove racist algorithms from clinical practice.

The U.S. can and should cautiously assess the U.K.’s vaccination strategy to avoid challenges that may impede its ability to control the virus.

The EUA pathway may impede vital scientific progress needed to establish the long term safety and efficacy of investigational COVID-19 vaccines.
